There are some types of cancer, including liver cance

er and stomach cancer, that are more common in China but are rare in the US,” he said, adding that cooperation on r

esearch for those cancers can help the US improve understanding of them and help China develop new drugs faster.

Chen said the potential for China’s cancer drug market is huge and dynamic. The market is projected to reach $30

billion by the year 2024, according to a recent report by US company Research and Markets.

Lung, breast and stomach cancer dominate the anti-cancer drug

market in China and are expected to do so in the near future, according to the report.

He said it’s good to see that there is a growing awareness regarding cancer treatment, diagnosis and drugs among Chi

nese people, and that the government also is investing more in healthcare infrastructure at the same time.

www.ashlf.cn